Psychedelic and ketamine research trials in Egypt

Data as of 11 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

5 registered studies are counted in Egypt. By compound: 5 ketamine. By registry status: 1 not yet recruiting, 3 completed and 1 status not reported. By phase: 1 phase 2, 2 phase 4 and 2 not applicable. Reported start years run from 2020 (earliest) to 2026 (latest). Studies are linked to 3 institutions.

Country is taken from the research site linked to each registry record. A study counts once, and a study tagged with more than one compound is counted under each compound. Ketamine studies are counted only when PsychoactiveMap classifies them as psychiatric research; anaesthesia, sedation and pain studies are left out.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

Recruiting now

1 of the 5 counted studies is listed in the registry as recruiting (0) or not yet recruiting (1), newest start first. Status is reported by study teams and can be out of date. PsychoactiveMap does not recruit, screen or refer anyone; eligibility and contact details are on each registry record.

Title as registered	Registry ID	Status	Phase	Start	Institution and city
Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain	NCT07250867	Not yet recruiting	Phase 2	2026-01-01	Assiut University, Asyut

At a glance

5 registered studies are counted on this page.

By compound

Compound hub	Studies
Ketamine	5

By registry status

Status	Studies	Share
Not yet recruiting	1	20%
Completed	3	60%
Status not reported	1	20%

By phase

Phase	Studies	Share
Phase 2	1	20%
Phase 4	2	40%
Not applicable	2	40%

When studies started

Start year	Studies
2024 to 2026	2
2020 to 2023	3

All counted studies

All 5 counted studies, newest start first. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.

Title as registered	Registry ID	Status	Phase	Start	Institution and city
Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain	NCT07250867	Not yet recruiting	Phase 2	2026-01-01	Assiut University, Asyut
Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder	NCT07526454	Completed	Not applicable	2025-07-01	Tanta University, Tanta
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion	NCT06060210	Completed	Phase 4	2023-10-29	Benha University, Banhā
Three Regimens of Ketamine Infusion in Complex Regional Pain Syndrome	NCT05997134	Status not reported	Phase 4	2023-08-30	Tanta University, Tanta
Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality	NCT04101474	Completed	Not applicable	2020-09-01	Assiut University, Asyut

About this data

Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.

Substance hubs for these compounds

Ketamine

Condition hubs

Condition hubs that include studies counted in this country, with the number of those studies. Conditions are matched by keyword on registered titles, so one study can appear under more than one condition.

Condition hub	Studies in this country
Depression	3
Treatment-resistant depression	2
Anxiety	1
Suicidal ideation and suicide risk	1

Other country hubs

All trial hubs | Learn | Disclaimer